JSLL
1 call
Concalls & earnings callsJeena Sikho Lifecare Limited
Every summarised call, newest first. Latest is Q1 FY27, held 10 Aug 2026.
Latest quarter
Q1 FY27 snapshot
Open full brief →Jeena Sikho reported strong growth driven by its integrated preventive healthcare model, focusing on a 30% YoY revenue growth target and expansion into luxury wellness and OTC products.
| Metric | This quarter | Change | Five-quarter trend |
|---|---|---|---|
| Revenue from Operations | ₹224 Cr | 29% YoY | |
| EBITDA | ₹92 Cr | 17% YoY | |
| PAT | ₹65 Cr | — | |
| EBITDA Margin | 41% | — |
Latest guidance
- Targeting year-on-year growth of about 30%.
- Aiming for a turnover of INR3,000 crores in about 3 years, maximum before 5 years.
- Long-term target of INR1,000 crores PAT.
- Goal to reach 7,000 to 10,000 beds in the next 3 to 5 years.
- Expect to maintain EBITDA margin of 40% plus and net profit margin of 27% to 30%.
- Plans to launch three to four more luxury premium wellness centers across India.
Said on the Q1 FY27 call.
Call history
- Q1 FY27Positive tone
Jeena Sikho reported strong growth driven by its integrated preventive healthcare model, focusing on a 30% YoY revenue growth target and expansion into luxury wellness and OTC products.
- Revenue from Operations
- ₹224 Cr29% YoY
- EBITDA
- ₹92 Cr17% YoY